Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. 8-K Event Executive or director change
  2. 8-K Event Shareholder vote results
  3. 8-K Event Other events
  4. 8-K Event Delisting notice
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Other events
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. 8-K Event Other events
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. 8-K Event Other events
  16. 8-K Event Other events
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 4 of 42 · 833 filings